Predictors of Pathologic Complete Response after Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study

Clinical Colorectal Cancer

Volumn 14, Issue 4, 2015, Pages 291-295

  Armstrong, Dawn ^a   Raissouni, Soundouss ^b   Price Hiller, Julie ^a   Mercer, Jamison ^c   Powell, Erin ^c   Maclean, Anthony ^d   Jiang, Maria ^e   Doll, Corinne ^b   Goodwin, Rachel ^f   Batuyong, Eugene ^b   Zhou, Kevin ^g   Monzon, Jose G ^b   Tang, Patricia A ^b   Heng, Daniel Y ^b   Cheung, Winson Y ^g   Vickers, Michael M ^f  

^a CROSS CANCER INSTITUTE   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c Dr H Bliss Murphy Cancer Centre   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f OTTAWA REGIONAL CANCER CENTRE   (Canada)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Carcinoembryonic antigen level; Neoadjuvant chemoradiation; Pathologic response; Predictive factors; Statin

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROPYRIMIDINE; FLUOROURACIL; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RALTITREXED;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATHOLOGIC COMPLETE RESPONSE; RECTUM CANCER; RECTUM CARCINOMA; RETROSPECTIVE STUDY; TREATMENT RESPONSE; BLOOD; CANADA; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; NEOADJUVANT THERAPY; PATHOLOGY; PROCEDURES; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

CANADA; CARCINOEMBRYONIC ANTIGEN; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84947869586     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2015.06.001     Document Type: Article

References (30)

1. Canadian Cancer Society. Colorectal Cancer Statistics. Available at: http://www.cancer.ca/en/cancer-information/cancer-type/colorectal/statistics/?region=nl Accessed January 9, 2015.
2. C. Allemani, H.K. Weir, H. Carreira, and et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet 385 2015 977 1010
3. National Cancer Institute. SEER Cancer Statistics Fact Sheets: Colon and Rectum Cancer. Web. Available at: http://seer.cancer.gov/statfacts/html/colorect.html. Accessed January 9, 2015.
4. R. Sauer, H. Becker, W. Hohenberger, and et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
5. P. Das, J.M. Skibber, M.A. Rodriguez-Bigas, and et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer Am J Clin Oncol 29 2006 219 224
6. I.D. Nagtegaal, and P. Quirke What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26 2008 303 312
7. I.D. Nagtegaal, M.J. Gosens, C.A. Marijnen, H.J. Rutten, C.J. van de Velde, and J.H.J. van Krieken Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer J Clin Oncol 25 2007 1647 1650
8. P. Sanghera, D.W.Y. Wong, C.C. McConkey, J.I. Geh, and A. Hartley Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response Clin Oncol 20 2008 176 183
9. M. Maas, P.J. Nelemans, V. Valentini, and et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
10. A. Habr-Gama, R.O. Perez, W. Nadalin, and et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 2004 711 717 discussion 717-8
11. M.J. O'Connell, L.H. Colangelo, R.W. Beart, and et al. Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04 J Clin Oncol 32 2014 1927 1934
12. A. Hartley, K.F. Ho, C. McConkey, and J.I. Geh Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials Br J Radiol 78 2005 934 938
13. M. Mohiuddin, W.F. Regine, W.J. John, and et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response Int J Radiat Oncol Biol Phys 46 2000 883 888
14. H.G. Moore, A.E. Gittleman, B.D. Minsky, and et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection Dis Colon Rectum 47 2004 279 286
15. H. Tulchinsky, E. Shmueli, A. Figer, J.M. Klausner, and M. Rabau An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer Ann Surg Oncol 15 2008 2661 2667
16. A. Habr-Gama, R.O. Perez, I. Proscurshim, and et al. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71 2008 1181 1188
17. L.E. Harrison, J.G. Guillem, P. Paty, and A.M. Cohen Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients J Am Coll Surg 185 1997 55 59
18. S.G. Yeo, D.Y. Kim, H.J. Chang, and et al. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy Tumori 99 2012 93 99
19. U. Wallin, D. Rothenberger, A. Lowry, R. Luepker, and A. Mellgren CEA-a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer Dis Colon Rectum 56 2013 859 868
20. J. Dulak, and A. Józkowicz Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy Curr Cancer Drug Targets 5 2005 579 594
21. K.K. Chan, A.M. Oza, and L.L. Siu The statins as anticancer agents Clin Cancer Res 9 2003 10 19
22. T. Nübel, J. Damrot, W.P. Roos, B. Kaina, and G. Fritz Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks Clin Cancer Res 12 2006 933 939
23. R.E. Langley, R.E. Langley, S.G. Quartuccio, P.T. Kennealey, C.N. Coleman, and E.A. Bump Effect of cell cycle stage, dose rate and repair of sublethal damage on radiation-induced apoptosis in F9 teratocarcinoma cells Radiat Res 144 1995 90 96
24. S.G. Sala, Ú. Muñoz, F. Bartolomé, F. Bermejo, and Á. Martín-Requero HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects J Pharmacol Exp Ther 324 2008 352 359
25. M.A. Kollmeier, M.S. Katz, K. Mak, and et al. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy Int J Radiat Oncol Biol Phys 79 2011 713 718
26. H.K. Tsai, M.S. Katz, J.J. Coen, A.L. Zietman, D.S. Kaufman, and W.U. Shipley Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer Urology 68 2006 1188 1192
27. M.S. Katz, B.D. Minsky, L.B. Saltz, E. Riedel, D.B. Chessin, and J.G. Guillem Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 62 2005 1363 1370
28. A.G. Mace, G.A. Gantt, M. Skacel, R. Pai, J.P. Hammel, and M.F. Kalady Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer Dis Colon Rectum 56 2013 1217 1227
29. E. Kapiteijn, C.A. Marijnen, I.D. Nagtegaal, and et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638 646
30. J.D. Smith, J.A. Ruby, K.A. Goodman, and et al. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy Ann Surg 256 2012 965 972